Corticosteroid-Induced Psychiatric Disorders: Mechanisms, Outcomes, and Clinical Implications
Diseases · 23.11.2024 · 12 (12) · 300
DOI: 10.3390/diseases12120300 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 23.11.2024. Verfasst von Lara Nasereddin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman 11937, Jordan. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Corticosteroids are extensively used in medicine for their powerful anti-inflammatory and immunosuppressive effects. However, their psychiatric side effects—such as mood disturbances, anxiety, and psychosis—are significant yet often underappreciated. This review provides a comprehensive exploration of corticosteroid-induced psychiatric disorders, with a focus on their underlying mechanisms and clinical implications. We examine how corticosteroids influence the hypothalamic–pituitary–adrenal (HPA) axis, leading to the dysregulation of stress responses and alterations in neurotransmitter levels, particularly dopamine, serotonin, and glutamate. These changes are linked to structural abnormalities in key brain areas such as the hippocampus and amygdala, which are implicated in mood and anxiety disorders, psychosis, and conditions like post-traumatic stress disorder (PTSD) and eating disorders. This review highlights the need for healthcare providers to be vigilant in recognizing and managing corticosteroid-induced psychiatric symptoms, especially in vulnerable populations with pre-existing mental health conditions. The complex relationship between corticosteroid type, dose, duration, and mental health outcomes is explored, emphasizing the importance of personalized treatment approaches to mitigate psychiatric risks. Given the widespread use of corticosteroids, there is an urgent need for more focused research on their psychiatric side effects. This review underscores the importance of patient education and careful monitoring to ensure optimal therapeutic outcomes while minimizing mental health risks associated with corticosteroid therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman 11937, Jordan.
- MEU Research Unit, Middle East University, Amman 11831, Jordan.
- Department of Pharmaceutical Sciences and Pharmaceutics, Applied Science Private University, Amman 11937, Jordan.
- Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.
ORCID-Profile: Lara Nasereddin, Dinesh Kumar Chellappan, Muna Barakat
Zitieren
APA
Nasereddin, L., Alnajjar, O., Bashar, H., Abuarab, S. F., Al-Adwan, R., Chellappan, D. K., & Barakat, M. (2024). Corticosteroid-Induced Psychiatric Disorders: Mechanisms, Outcomes, and Clinical Implications. Diseases, 12(12), 300. https://doi.org/10.3390/diseases12120300
Vancouver
Nasereddin L, Alnajjar O, Bashar H, Abuarab SF, Al-Adwan R, Chellappan DK, et al. Corticosteroid-Induced Psychiatric Disorders: Mechanisms, Outcomes, and Clinical Implications. Diseases. 2024;12(12):300. doi:10.3390/diseases12120300
BibTeX
@article{Nasereddin2024,
author = {Nasereddin, Lara and Alnajjar, Omar and Bashar, Homam and Abuarab, Sara Feras and Al-Adwan, Rahma and Chellappan, Dinesh Kumar and Barakat, Muna},
title = {Corticosteroid-Induced Psychiatric Disorders: Mechanisms, Outcomes, and Clinical Implications},
journal = {Diseases},
year = {2024},
volume = {12},
number = {12},
pages = {300},
doi = {10.3390/diseases12120300}
}
EUVIMED